The ESG (Environmental, Social and Governance) criteria measure the extent to which an economic actor operates in a sustainable and responsible manner, not only from an economic perspective, but also from an environmental, social and governance standpoint. These criteria are strongly aligned with the United Nations’ 2030 Agenda for Sustainable Development, which has helped strengthen sustainability as a strategic objective.
The ESG principles (Environmental, Social and Governance) are, in every respect, driving forces behind the transformation of the global economic and production system: sustainability is no longer an option, but a strategic necessity for economic actors seeking to create long-term value and respond responsibly to society’s expectations.
This represents a profound cultural shift, redefining each Organization’s responsibility towards the environment, people and the communities in which it operates, while establishing a common and shared language through which responsibility can be measured. Alongside traditional economic and financial metrics, these criteria affect reputation, attractiveness to investors, access to credit and credit ratings, directly influencing competitiveness and medium- to long-term performance.
Pharmaceutical companies, medical device companies and Third Sector Organizations operating in the healthcare sector are particularly involved in this transformation, given the direct impact they have on people’s health, well-being and quality of life. Responsible innovation, transparency and sustainable processes are therefore becoming essential elements for ethical and long-lasting development.
PROMOTERS:
Within this context, BFC Media, the publishing group of Forbes Italia, a global benchmark brand for all stakeholders committed to creating economic value; Pro Format Comunicazione, a leading company specializing in consulting, public relations and communications in the healthcare sector; and MP FILM, a company dedicated to producing audiovisual content for communications related to the healthcare industry—leveraging the synergies among their respective areas of expertise and fields of activity—are promoting the second edition of the “Forbes ESG – Sustainability Pharma Awards”.
The objective is to build continuity on the successful initiative launched in 2025, recognizing and showcasing the achievements of Organizations that have demonstrated excellence in the ESG field.
Professor Elisa Giuliani will present the awards in the following categories:
- Best Project to Address Social Inequalities
- Best Project for Employee Engagement in ESG Activities
